Via the incretin pathway, they stimulate insulin release, suppress glucagon release, slow down gastric emptying, and enhance central satiety signal
Store lyophilized material at 28C, protected from light and moisture
The Rise of GLP1 Drugs for Weight Loss GLP-1 (Glucagon-Like Peptide-1) receptor agonists are a revolutionary class of injectable or oral medications originally developed for type 2 diabetes, but now widely used for chronic weight management
Why Connecticut Patients Choose Our Approach Medication + Habits: Professional guidelines recommend pairing anti-obesity meds with lifestyle changes
New York, NY: Springer (2014)
According to Laura Buford, MD, factors such as genetics, lifestyle and underlying health conditions all play a role in how an individual responds to these treatments